Literature DB >> 21278330

Promising antiapoptotic effects of helix B-surface peptide (HBSP) for treatment of heart diseases.

Eltyeb Abdelwahid, Graham Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21278330      PMCID： PMC3038717          DOI： 10.1073/pnas.1012530108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases.

Authors:  Zhao Zhong Chong; Jing-Qiong Kang; Kenneth Maiese
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

Review 2.  Molecular basis of cardioprotection by erythropoietin.

Authors:  D Burger; A Xenocostas; Q P Feng
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

3.  Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin.

Authors:  Hiroto Ueba; Michael Brines; Michael Yamin; Tomio Umemoto; Junya Ako; Shin-ichi Momomura; Anthony Cerami; Masanobu Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

4.  TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways.

Authors:  Sandra B Haudek; George E Taffet; Michael D Schneider; Douglas L Mann
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

5.  A novel protective effect of erythropoietin in the infarcted heart.

Authors:  Cyrus J Parsa; Akio Matsumoto; Jihee Kim; Ryan U Riel; Laura S Pascal; G Brant Walton; Richard B Thompson; Jason A Petrofski; Brian H Annex; Jonathan S Stamler; Walter J Koch
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.